UnicoCell

  • About
  • Cell Therapy
  • Products & services
  • News
  • Contact
  • 中文 / EN

News

  • 2025.07.29 UnicoCell Biomed (6794) Received Confirmation of Listing Transfer to General Board Allogeneic Stem Cell New Drug Pioneer Enters New Phase in Capital Markets
  • 2025.03.24 UnicoCell Emphasizes Safety and Quality Control of Exosome Products (excerpt from Business Weekly (1949th issue) : Exosome Trend)
  • 2025.03.12 Unicocell Biomed Co., Ltd. Receives FDA Fast Track Designation
  • 2025.03.07 UnicoCell has received approval from the Ministry of Health and Welfare for the extension of its "Human Organ Bank" license
  • 2025.03.05 UnicoCell with successive good news PIC/S GMP pilot plant certification from the Ministry of Health and Welfare
  • 2025.02.24 Mentor Group and UnicoCell Biomed Form Strategic Alliance

Products & services
  • Conditioned Medium
    Conditioned Medium
    MORE
  • Mass Production and CDMO
    Mass Production and CDMO
    MORE
  • Autologous Stem Cell Therapy
    Autologous Stem Cell Therapy
    MORE
  • Allogeneic Adipose Stem Cell Bank
    Allogeneic Adipose Stem Cell Bank
    MORE
向榮生醫科技

11494 台北市內湖區民權東路六段13之20號5樓

Tel:886-2-2792-2699 FAX:886-2-2792-7890

E-Mail : info@unicocell.com

LinkedIn Facebook Line
Copyright © 2018-2025 向榮生醫科技股份有限公司